tetano
Editor, Senior Moderator
Vaccines (Basel)
. 2022 Sep 7;10(9):1491.
doi: 10.3390/vaccines10091491.
Microneedle Delivery of an Adjuvanted Microparticulate Vaccine Induces High Antibody Levels in Mice Vaccinated against Coronavirus
Sharon Vijayanand[SUP] 1 [/SUP], Smital Patil[SUP] 1 [/SUP], Devyani Joshi[SUP] 1 [/SUP], Ipshita Menon[SUP] 1 [/SUP], Keegan Braz Gomes[SUP] 1 [/SUP], Akanksha Kale[SUP] 1 [/SUP], Priyal Bagwe[SUP] 1 [/SUP], Shadi Yacoub[SUP] 1 [/SUP], Mohammad N Uddin[SUP] 1 [/SUP], Martin J D'Souza[SUP] 1 [/SUP]
Affiliations
Abstract
This 'proof-of-concept' study aimed to test the microparticulate vaccine delivery system and a transdermal vaccine administration strategy using dissolving microneedles (MN). For this purpose, we formulated poly(lactic-co-glycolic) acid (PLGA) microparticles (MP) encapsulating the inactivated canine coronavirus (iCCoV), as a model antigen, along with adjuvant MP encapsulating Alhydrogel[SUP]®[/SUP] and AddaVax. We characterized the vaccine MP for size, surface charge, morphology, and encapsulation efficiency. Further, we evaluated the in vitro immunogenicity, cytotoxicity, and antigen-presentation of vaccine/adjuvant MP in murine dendritic cells (DCs). Additionally, we tested the in vivo immunogenicity of the MP vaccine in mice through MN administration. We evaluated the serum IgG, IgA, IgG1, and IgG2a responses using an enzyme-linked immunosorbent assay. The results indicate that the particulate form of the vaccine is more immunogenic than the antigen suspension in vitro. We found the vaccine/adjuvant MP to be non-cytotoxic to DCs. The expression of antigen-presenting molecules, MHC I/II, and their costimulatory molecules, CD80/40, increased with the addition of the adjuvants. Moreover, the results suggest that the MP vaccine is cross presented by the DCs. In vivo, the adjuvanted MP vaccine induced increased antibody levels in mice following vaccination and will further be assessed for its cell-mediated responses.
Keywords: antibody response; antigen presentation; cytotoxicity; immunogenicity; microneedles; microparticles.
. 2022 Sep 7;10(9):1491.
doi: 10.3390/vaccines10091491.
Microneedle Delivery of an Adjuvanted Microparticulate Vaccine Induces High Antibody Levels in Mice Vaccinated against Coronavirus
Sharon Vijayanand[SUP] 1 [/SUP], Smital Patil[SUP] 1 [/SUP], Devyani Joshi[SUP] 1 [/SUP], Ipshita Menon[SUP] 1 [/SUP], Keegan Braz Gomes[SUP] 1 [/SUP], Akanksha Kale[SUP] 1 [/SUP], Priyal Bagwe[SUP] 1 [/SUP], Shadi Yacoub[SUP] 1 [/SUP], Mohammad N Uddin[SUP] 1 [/SUP], Martin J D'Souza[SUP] 1 [/SUP]
Affiliations
- PMID: 36146568
- DOI: 10.3390/vaccines10091491
Abstract
This 'proof-of-concept' study aimed to test the microparticulate vaccine delivery system and a transdermal vaccine administration strategy using dissolving microneedles (MN). For this purpose, we formulated poly(lactic-co-glycolic) acid (PLGA) microparticles (MP) encapsulating the inactivated canine coronavirus (iCCoV), as a model antigen, along with adjuvant MP encapsulating Alhydrogel[SUP]®[/SUP] and AddaVax. We characterized the vaccine MP for size, surface charge, morphology, and encapsulation efficiency. Further, we evaluated the in vitro immunogenicity, cytotoxicity, and antigen-presentation of vaccine/adjuvant MP in murine dendritic cells (DCs). Additionally, we tested the in vivo immunogenicity of the MP vaccine in mice through MN administration. We evaluated the serum IgG, IgA, IgG1, and IgG2a responses using an enzyme-linked immunosorbent assay. The results indicate that the particulate form of the vaccine is more immunogenic than the antigen suspension in vitro. We found the vaccine/adjuvant MP to be non-cytotoxic to DCs. The expression of antigen-presenting molecules, MHC I/II, and their costimulatory molecules, CD80/40, increased with the addition of the adjuvants. Moreover, the results suggest that the MP vaccine is cross presented by the DCs. In vivo, the adjuvanted MP vaccine induced increased antibody levels in mice following vaccination and will further be assessed for its cell-mediated responses.
Keywords: antibody response; antigen presentation; cytotoxicity; immunogenicity; microneedles; microparticles.